The melanocortin receptor agonist bremelanotide* appears to be effective for postmenopausal women with female sexual arousal disorder,
2002 ◽
Vol 28
(sup1)
◽
pp. 205-215
◽
2008 ◽
Vol 38
(4)
◽
pp. 463-475
◽
2009 ◽
Vol 6
(12)
◽
pp. 3385-3394
◽
2007 ◽
Vol 15
(1)
◽
pp. 142-159
◽
2006 ◽
Vol 3
(4)
◽
pp. 628-638
◽
2006 ◽
Vol 49
(14)
◽
pp. 4409-4424
◽
2000 ◽
Vol 95
(6)
◽
pp. S54
◽
2003 ◽
Vol 29
(5)
◽
pp. 329-344
◽